McCaleb ML - Search Results

1

Studies on new acidic azoles as glucose-lowering agents in obese, diabetic db/db mice.

Kees KL, Caggiano TJ, Steiner KE, Fitzgerald JJ Jr, Kates MJ, Christos TE, Kulishoff JM Jr, Moore RD, McCaleb ML. Kees KL, et al. Among authors: mccaleb ml. J Med Chem. 1995 Feb 17;38(4):617-28. doi: 10.1021/jm00004a008. J Med Chem. 1995. PMID: 7861410

2

Perfluorocarbon-based antidiabetic agents.

Kees KL, Smith TM, McCaleb ML, Prozialeck DH, Cheeseman RS, Christos TE, Patt WC, Steiner KE. Kees KL, et al. Among authors: mccaleb ml. J Med Chem. 1992 Mar 6;35(5):944-53. doi: 10.1021/jm00083a021. J Med Chem. 1992. PMID: 1548684

3

New potent antihyperglycemic agents in db/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and -pyrazolones.

Kees KL, Fitzgerald JJ Jr, Steiner KE, Mattes JF, Mihan B, Tosi T, Mondoro D, McCaleb ML. Kees KL, et al. Among authors: mccaleb ml. J Med Chem. 1996 Sep 27;39(20):3920-8. doi: 10.1021/jm960444z. J Med Chem. 1996. PMID: 8831758

4

Novel 5-(3-aryl-2-propynyl)-5-(arylsulfonyl)thiazolidine-2,4-diones as antihyperglycemic agents.

Wrobel J, Li Z, Dietrich A, McCaleb M, Mihan B, Sredy J, Sullivan D. Wrobel J, et al. J Med Chem. 1998 Mar 26;41(7):1084-91. doi: 10.1021/jm9706168. J Med Chem. 1998. PMID: 9544208

5

Antihyperglycemic activity of new 1,2,4-oxadiazolidine-3,5-diones.

Malamas MS, Sredy J, McCaleb M, Gunawan I, Mihan B, Sullivan D. Malamas MS, et al. Eur J Med Chem. 2001 Jan;36(1):31-42. doi: 10.1016/s0223-5234(00)01191-0. Eur J Med Chem. 2001. PMID: 11231047

6

Antihyperglycemic activity of novel substituted 3H-1,2,3,5-oxathiadiazole 2-oxides.

Ellinboe JW, Alessi TR, Dolak TM, Nguyen TT, Tomer JD, Guzzo F, Bagli JF, McCaleb ML. Ellinboe JW, et al. Among authors: mccaleb ml. J Med Chem. 1992 Apr 3;35(7):1176-83. doi: 10.1021/jm00085a002. J Med Chem. 1992. PMID: 1560432

7

Novel spirosuccinimides with incorporated isoindolone and benzisothiazole 1,1-dioxide moieties as aldose reductase inhibitors and antihyperglycemic agents.

Wrobel J, Dietrich A, Woolson SA, Millen J, McCaleb M, Harrison MC, Hohman TC, Sredy J, Sullivan D. Wrobel J, et al. J Med Chem. 1992 Nov 27;35(24):4613-27. doi: 10.1021/jm00102a016. J Med Chem. 1992. PMID: 1469692

8

Synthesis and antihyperglycemic activity of novel 5-(naphthalenylsulfonyl)-2,4-thiazolidinediones.

Zask A, Jirkovsky I, Nowicki JW, McCaleb ML. Zask A, et al. Among authors: mccaleb ml. J Med Chem. 1990 May;33(5):1418-23. doi: 10.1021/jm00167a022. J Med Chem. 1990. PMID: 2329563

9

Prevention of urinary albumin excretion in 6 month streptozocin-diabetic rats with the aldose reductase inhibitor tolrestat.

McCaleb ML, Sredy J, Millen J, Ackerman DM, Dvornik D. McCaleb ML, et al. J Diabet Complications. 1988 Jan-Mar;2(1):16-8. doi: 10.1016/0891-6632(88)90020-7. J Diabet Complications. 1988. PMID: 2968349

10

Intervention with the aldose reductase inhibitor, tolrestat, in renal and retinal lesions of streptozotocin-diabetic rats.

McCaleb ML, McKean ML, Hohman TC, Laver N, Robison WG Jr. McCaleb ML, et al. Diabetologia. 1991 Oct;34(10):695-701. doi: 10.1007/BF00401513. Diabetologia. 1991. PMID: 1959701

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters